Health
Oxford says its candidate has great immune reaction with two dose regime – Microbioz India
The vaccine candidate, which has been licensed to AstraZeneca, has published interim late stage trial results showing higher efficacy when a half dose is followed…
The vaccine candidate, which has been licensed to AstraZeneca, has published interim late stage trial results showing higher efficacy when a half dose is followed by a complete dose, in contrast to a two full-dose regime, though more work needs to be done to affirm the outcome.
The details from the Phase I/II clinical trials released on December 17 made no reference to the half-dose/full-dose regime, which Oxford has said had been”unplanned” but accepted by regulators.
The university said it had…
-
General14 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News14 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Business20 hours agoInvested $10,000 in Westpac shares 2 years ago? Guess how much you’ve already banked!